Deborah Lynn Parkes

Title: Innovations in Retroviral Research by Deborah Lynn Parkes

Introduction

Deborah Lynn Parkes is a prominent inventor based in Oakland, CA (US), known for her significant contributions to the field of retroviral research. With a total of 9 patents, her work has advanced the understanding and treatment of retroviral infections, particularly HIV.

Latest Patents

Parkes' latest patents include groundbreaking innovations such as a purified pol DNA and a recombinant DNA construct for the expression of HIV pol polypeptide sequences. These inventions provide essential polynucleotide sequences for diagnosing the presence of retroviral infections in human hosts associated with lymphadenopathy syndrome and acquired immune deficiency syndrome. The polypeptides and antibodies derived from her work can be utilized as diagnostic reagents or in therapeutic applications, including vaccines and passive immunization. Additionally, her method for expressing HIV polypeptides further enhances the detection of viral infectious agents linked to these syndromes.

Career Highlights

Throughout her career, Deborah Lynn Parkes has worked with notable organizations, including Novartis Vaccines & Diagnostics and Chiron Corporation. Her expertise in the field has led to significant advancements in the development of diagnostic and therapeutic tools for retroviral infections.

Collaborations

Parkes has collaborated with esteemed colleagues such as Paul A. Luciw and Dino Dina, contributing to a rich exchange of ideas and innovations in her research endeavors.

Conclusion

Deborah Lynn Parkes continues to be a vital figure in the realm of retroviral research, with her patents paving the way for new diagnostic and therapeutic strategies. Her work exemplifies the impact of innovation in addressing critical health challenges.